报价延迟最少15分钟:2026/03/12 12:59 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
58.01 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
4.89/2.18
|
|
企业价值
1.74B
|
| 资产负债 |
|
每股账面净值
27.32
|
| 现金流量 |
|
现金流量率
0.07
|
| 损益表 |
|
收益
911.98M
|
|
每股收益
19.94
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region. |
